Zobrazeno 1 - 10 of 15 pro vyhledávání: '"Hella, Danø"'
1
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer
Autor: Charlotte Buch Jensen, Peter Michael Vestlev, Erik Jakobsen, Hella Danø, Sven Tyge Langkjer, T. Dongsgaard, Adam Luczak, J. Neimann, Anne Sofie Brems-Eskildsen, Søren Linnet
Publikováno v: Brems-Eskildsen, A S, Linnet, S, Danø, H, Luczak, A, Vestlev, P M, Jakobsen, E H, Neimann, J, Jensen, C B, Dongsgaard, T & Langkjer, S T 2021, ' Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer ', Acta Oncologica, vol. 60, no. 2, pp. 157-164 . https://doi.org/10.1080/0284186X.2020.1851045
Background: Metronomic treatment is hypothesized to be less toxic and more effective as compared to standard maximal tolerable dosing treatment in metastatic cancer disease. Material and methods: We tested the metronomic treatment principle with vino
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2101a4cbcc0032e69ac0121949ed806f
https://vbn.aau.dk/da/publications/76bfbc2e-c9a4-4913-af91-571e16566305
Zobrazit plný text záznamu
2
Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial
Autor: Søren Cold, Marianne Ewertz, Hanne Melgaard Nielsen, Julia Kenholm, Dorte Carlsen, Malgorzata K Tuxen, Ann Knoop, Eva Balslev, Troels Bechmann, Erik Jakobsen, Hella Danø, Michael Andersson, Dorte Nielsen, Inger Højris, Henning T. Mouridsen, Bent Ejlertsen, Else Maae, Peter Michael Vestlev, Maj-Britt Jensen
Publikováno v: Ejlertsen, B, Tuxen, M K, Jakobsen, E H, Jensen, M-B, Knoop, A S, Højris, I, Ewertz, M, Balslev, E, Danø, H, Vestlev, P M, Kenholm, J, Nielsen, D L, Bechmann, T, Andersson, M, Cold, S, Nielsen, H M, Maae, E, Carlsen, D & Mouridsen, H T 2017, ' Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial ', Journal of Clinical Oncology, vol. 35, no. 23, pp. 2639-2646 . https://doi.org/10.1200/JCO.2017.72.3494
Ejlertsen, B, Tuxen, M K, Jakobsen, E H, Jensen, M-B, Knoop, A S, Højris, I, Ewertz, M, Balslev, E, Danø, H, Vestlev, P M, Kenholm, J, Nielsen, D L, Bechmann, T, Andersson, M, Cold, S, Nielsen, H M, Maae, E, Carlsen, D & Mouridsen, H T 2017, ' Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer : DBCG 07-READ, an Open-Label, Phase III, Randomized Trial ', Journal of Clinical Oncology, vol. 35, no. 23, pp. 2639-2646 . https://doi.org/10.1200/JCO.2017.72.3494
Purpose Administration of anthracycline and taxane therapy in the adjuvant setting is considered a standard for breast cancer. We evaluated a non-anthracycline-based regimen in TOP2A-normal patients. Patients and Methods In this multicenter, open-lab
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d31fe2d3f63dba4f1402d624553e76
https://doi.org/10.1200/jco.2017.72.3494
Zobrazit plný text záznamu
4
The NAME trial: a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer
Autor: T. Dongsgaard, Sven Tyge Langkjer, Lars Stenbygaard, Helle Lemvig Kruse, Julia Kenholm, Anne Sofie Brems-Eskildsen, Jeanette Dupont Jensen, Hella Danø, Bjørnar Gilje, Kim Wedervang, J. Neimann, Jürgen Geisler, Erik Hugger Jacobsen, Vesna Glavicic, Mie Grunnet, Annette Torbøl Brixen
Publikováno v: Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : A direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124
Chemotherapy for metastatic breast cancer (MBC) is in general given in cycles of maximum tolerated doses to potentially maximize the therapeutic outcome. However, when compared with targeted therapies for MBC, conventional and dose intensified chemot
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3e68144dbea7113137cab419868c36
http://hdl.handle.net/10852/77735
Zobrazit plný text záznamu
5
DBCG-IMN:A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer
Autor: S.J. Zimmermann, Hella Danø, Jens Overgaard, Marie Overgaard, Ingelise Jensen, Martin Berg, Hans-Jürgen Brodersen, Lise Bech Jellesmark Thorsen, Birgitte Vrou Offersen, Anders N. Pedersen
Publikováno v: Thorsen, L B J, Offersen, B V, Danø, H, Berg, M, Jensen, I, Pedersen, A N, Zimmermann, S J, Brodersen, H-J, Overgaard, M & Overgaard, J 2016, ' DBCG-IMN : A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 34, no. 4, pp. 314-320 . https://doi.org/10.1200/JCO.2015.63.6456
Thorsen, L B J, Offersen, B V, Danø, H, Berg, M, Jensen, I, Pedersen, A N, Zimmermann, S J, Brodersen, H-J, Overgaard, M & Overgaard, J 2016, ' DBCG-IMN : A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer ', Journal of Clinical Oncology, vol. 34, no. 4, pp. 314-320 . https://doi.org/10.1200/jco.2015.63.6456
Thorsen, L B J, Offersen, B V, Danø, H, Berg, M, Jensen, I, Pedersen, A N, Zimmermann, S J, Brodersen, H-J, Overgaard, M & Overgaard, J 2016, ' DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer ', Journal of Clinical Oncology, vol. 34, no. 4, pp. 314-20 . https://doi.org/10.1200/JCO.2015.63.6456
Purpose It is unknown whether irradiation of the internal mammary lymph nodes improves survival in patients with early-stage breast cancer. A possible survival benefit might be offset by radiation-induced heart disease. We assessed the effect of inte
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292354dfe7ceb7c70aa861e0c4a22878
https://vbn.aau.dk/da/publications/778e4cd5-c5ff-49f1-909e-60f0b6e827e9
Zobrazit plný text záznamu
6
The NAME trial: A direct comparison of oral navelbine given either classic or metronomic in metastatic HER2 neg breast cancer
Autor: E. H. Jacobsen, Annette Torbøl Brixen, Lars Stenbygaard, H.L. Kruse, J. Neimann, Julia Kenholm, M. Grunnet, Jürgen Geisler, Anne Sofie Brems-Eskildsen, K. Wedervang, Sven Tyge Langkjer, Jeanette Dupont Jensen, Vesna Glavicic, T. Dongsgaard, Hella Danø
Publikováno v: Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2018, ' The NAME trial : A direct comparison of oral navelbine given either classic or metronomic in metastatic HER2 neg breast cancer ', Annals of Oncology, vol. 29, no. Suppl. 8, 366TiP, pp. viii120 . https://doi.org/10.1093/annonc/mdy272.354
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Dano, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2018, ' The NAME trial: A direct comparison of oral navelbine given either classic or metronomic in metastatic HER2 neg breast cancer ', Annals of Oncology, vol. 29, no. Suppl. 8, pp. viii120 . https://doi.org/10.1093/annonc/mdy272.354
Background: Navebine is an antineplastic agent that has shown afficacy in the treatment of a variety of solid tumors, including breast cancer. The drug can be given intriavenously, but also as oral tablet treatment. Preclinical studies, as well as cl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::575b48a23ba570b0569b579d24d75308
https://doi.org/10.1093/annonc/mdy272.354
Zobrazit plný text záznamu
7
Fertility pattern does not explain social gradient in breast cancer in denmark
Autor: Marianne Ewertz, Kasper D. Hansen, Elsebeth Lynge, Jørgen Holm Petersen, Per Anker Jensen, Hella Danø, Rune Jacobsen
Publikováno v: International Journal of Cancer. 111:451-456
The present study was undertaken to assess the impact of reproductive behavior on the social class gradient in breast cancer occurrence in Denmark. Objectives were to study whether the gradient across socioeconomic groups could be explained by fertil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ed494ddc34d07592dd77d8896bd50e7
https://doi.org/10.1002/ijc.20203
Zobrazit plný text záznamu
8
Fertility pattern does not explain social gradient in breast cancer in denmark
Autor: Hella, Danø, Kasper Daniel, Hansen, Per, Jensen, Jørgen Holm, Petersen, Rune, Jacobsen, Marianne, Ewertz, Elsebeth, Lynge
Publikováno v: International journal of cancer. 111(3)
The present study was undertaken to assess the impact of reproductive behavior on the social class gradient in breast cancer occurrence in Denmark. Objectives were to study whether the gradient across socioeconomic groups could be explained by fertil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::956bab9cb5bfc18e702bbb51a6ffdced
https://pubmed.ncbi.nlm.nih.gov/15221976
Zobrazit plný text záznamu
9
Fertility pattern does not explain social gradient in breast cancer in Denmark
Autor: Hella Danø, Hansen, K. D., Jensen, P., Jørgen Holm Petersen, Rune Jacobsen, Ewertz, M., Elsebeth Lynge
Publikováno v: Dano, H, Hansen, K D, Jensen, P, Petersen, J H, Jacobsen, R, Ewertz, M & Lynge, E 2004, ' Fertility pattern does not explain social gradient in breast cancer in Denmark ' International Journal of Cancer, vol. 111, no. 3, pp. 451-456 .
Danø, H, Hansen, K D, Jensen, P, Petersen, J H, Jacobsen, R, Ewertz, M & Lynge, E 2004, ' Fertility pattern does not explain social gradient in breast cancer in Denmark ', International Journal of Cancer, vol. 111, no. 3, pp. 451-6 . https://doi.org/10.1002/ijc.20203
University of Copenhagen
The present study was undertaken to assess the impact of reproductive behavior on the social class gradient in breast cancer occurrence in Denmark. Objectives were to study whether the gradient across socioeconomic groups could be explained by fertil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9074e49841e643d154e897a3292b6401
https://pure.au.dk/portal/da/publications/fertility-pattern-does-not-explain-social-gradient-in-breast-cancer-in-denmark(7654e620-9562-11da-bee9-02004c4f4f50).html
Zobrazit plný text záznamu
10
Underreporting of occupational cancers in Denmark
Autor: Hella Danø, Torsten Skov, Elsebeth Lynge
Publikováno v: Europe PubMed Central
Objectives The goal of the study was to investigate whether the reporting of occupational cancers has improved in Denmark since 1987 and whether medical records currently have better information on occupational exposures. Methods All cases of pleural
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646999f2730646d8671d260f76aee5ff
https://pubmed.ncbi.nlm.nih.gov/8685675
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje